• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人患者接受单倍体相合或单份脐带血造血干细胞移植的输血需求比较。

Comparison of transfusion requirements in adult patients undergoing Haploidentical or single-unit umbilical cord blood stem cell transplantation.

机构信息

Blood Bank, Hospital Universitari I Politècnic La Fe, Valencia, Spain.

CIBERONC, Instituto Carlos III, Madrid, Spain.

出版信息

Eur J Haematol. 2019 Sep;103(3):172-177. doi: 10.1111/ejh.13270. Epub 2019 Jul 3.

DOI:10.1111/ejh.13270
PMID:31177565
Abstract

OBJECTIVES

Umbilical cord blood transplantation (UCBT) and haploidentical hematopoietic stem cell transplantation (haplo-HSCT) modalities have been developed to offset the lack of matched donors. In this study, we compare the transfusion requirements of patients undergoing UCBT and haplo-HSCT in a single institution with the aim of providing additional information for clinicians to choose the most adequate alternative graft for HSCT.

METHODS

The study reviewed 67 and 46 patients undergoing UCBT and haplo-HSCT, respectively.

RESULTS

There were no significant differences for RBC and PLT requirements according to the transplantation modality. Median time to RBC transfusion independence was 35 and 25.5 days in patients who received an UCBT and haplo-HSCT, respectively (P = 0.38), while median time to platelet transfusion independence was 31 days for UCBT patients and 23 for haplo-HSCT patients (P < 0.001). Days until neutrophils > 0.5 × 10 /L were the only variable that significantly influenced RBC and PLT requirements for both transplantation modalities. Cumulative incidence of RBC and PLT transfusion independence at 90 days after transplantation was similar for both UCBT and haplo-HSCT.

CONCLUSIONS

Both transplantation platforms require prolonged and intensive supportive RBC and PLT transfusion therapy. Both transplantation platforms require prolonged and intensive supportive RBC and PLT transfusion therapy.

摘要

目的

为了弥补匹配供体的缺乏,开发了脐带血移植(UCBT)和单倍体造血干细胞移植(haplo-HSCT)。本研究比较了单中心接受 UCBT 和 haplo-HSCT 的患者的输血需求,旨在为临床医生提供更多信息,选择最适合 HSCT 的替代移植物。

方法

本研究分别回顾了 67 例和 46 例接受 UCBT 和 haplo-HSCT 的患者。

结果

根据移植方式,RBC 和 PLT 的需求没有显著差异。接受 UCBT 和 haplo-HSCT 的患者 RBC 输血独立的中位时间分别为 35 天和 25.5 天(P=0.38),而血小板输血独立的中位时间分别为 UCBT 患者的 31 天和 haplo-HSCT 患者的 23 天(P<0.001)。中性粒细胞>0.5×10/L 的天数是唯一显著影响两种移植方式 RBC 和 PLT 需求的变量。移植后 90 天 RBC 和 PLT 输血独立的累积发生率在 UCBT 和 haplo-HSCT 之间相似。

结论

两种移植平台均需要长期和强化的支持性 RBC 和 PLT 输血治疗。

相似文献

1
Comparison of transfusion requirements in adult patients undergoing Haploidentical or single-unit umbilical cord blood stem cell transplantation.成人患者接受单倍体相合或单份脐带血造血干细胞移植的输血需求比较。
Eur J Haematol. 2019 Sep;103(3):172-177. doi: 10.1111/ejh.13270. Epub 2019 Jul 3.
2
Comparison of outcomes after umbilical cord blood and unmanipulated haploidentical hematopoietic stem cell transplantation in children with high-risk acute lymphoblastic leukemia.高危急性淋巴细胞白血病患儿脐带血与未处理单倍体造血干细胞移植后结局的比较
Int J Cancer. 2016 Nov 1;139(9):2106-15. doi: 10.1002/ijc.30249. Epub 2016 Jul 15.
3
Transfusion Burden in Allogeneic Hematopoietic Stem Cell Transplantation over Time: Experience from a Single Institution.异基因造血干细胞移植中随时间变化的输血负担:来自单一机构的经验
J Clin Med. 2023 May 15;12(10):3467. doi: 10.3390/jcm12103467.
4
Transfusion burden following reduced intensity allogeneic hematopoietic cell transplantation: Impact of donor type.同种异体造血细胞移植后输血负担:供者类型的影响。
Transfusion. 2021 Jul;61(7):2064-2074. doi: 10.1111/trf.16413. Epub 2021 Apr 26.
5
ABO incompatibility does not influence transfusion requirements in patients undergoing single-unit umbilical cord blood transplantation.ABO血型不相容不影响接受单单位脐血移植患者的输血需求。
Bone Marrow Transplant. 2017 Mar;52(3):394-399. doi: 10.1038/bmt.2016.264. Epub 2016 Oct 31.
6
RBC and platelet transfusion support in the first 30 and 100 days after haploidentical hematopoietic stem cell transplantation.在单倍体造血干细胞移植后第 30 和 100 天进行 RBC 和血小板输血支持。
Transfusion. 2019 Nov;59(11):3371-3385. doi: 10.1111/trf.15531. Epub 2019 Oct 10.
7
Haplo-Cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML.单倍体脐带血移植与单倍体相合移植加移植后环磷酰胺治疗 AML 患者的比较。
Bone Marrow Transplant. 2017 Aug;52(8):1138-1143. doi: 10.1038/bmt.2017.36. Epub 2017 Mar 27.
8
Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.单倍体相合细胞辅助减强度预处理下单单位脐带血移植后脐带血移植物失败的频率及危险因素
Biol Blood Marrow Transplant. 2016 Jun;22(6):1065-1072. doi: 10.1016/j.bbmt.2016.02.010. Epub 2016 Feb 19.
9
Red blood cell and platelet transfusion support in the first 30 and 100 days after allogeneic hematopoietic cell transplant.异基因造血细胞移植后前30天和100天的红细胞和血小板输血支持
Transfusion. 2020 Oct;60(10):2225-2242. doi: 10.1111/trf.15961. Epub 2020 Aug 3.
10
Umbilical cord blood transplantation and unmanipulated haploidentical hematopoietic SCT for pediatric hematologic malignances.脐带血移植和未处理的单倍体相合造血干细胞移植治疗小儿血液系统恶性肿瘤。
Bone Marrow Transplant. 2014 Aug;49(8):1070-5. doi: 10.1038/bmt.2014.109. Epub 2014 Jun 2.

引用本文的文献

1
Favorable outcomes and the association between dynamic transfusion dependence and IPSS-M in MDS-h and MDS-LB patients undergoing allo-HSCT.接受异基因造血干细胞移植的骨髓增生异常综合征-低危组(MDS-h)和低原始细胞比例骨髓增生异常综合征(MDS-LB)患者的良好预后以及动态输血依赖与国际预后评分系统-骨髓(IPSS-M)之间的关联。
Bone Marrow Transplant. 2025 Apr 25. doi: 10.1038/s41409-025-02613-2.
2
Toward Digital Periodontal Health: Recent Advances and Future Perspectives.迈向数字化牙周健康:最新进展与未来展望。
Bioengineering (Basel). 2024 Sep 18;11(9):937. doi: 10.3390/bioengineering11090937.
3
Transfusion Burden in Allogeneic Hematopoietic Stem Cell Transplantation over Time: Experience from a Single Institution.
异基因造血干细胞移植中随时间变化的输血负担:来自单一机构的经验
J Clin Med. 2023 May 15;12(10):3467. doi: 10.3390/jcm12103467.